Asia’s emergence in cancer immunotherapy: challenges and opportunities
Asia’s role in cancer immunotherapy research is rapidly expanding, driven by cutting-edge facilities, innovative technologies, and collaborative efforts. This commentary examines the region’s growing impact, highlighting key clinical trials, emerging research hubs, and unique challenges that we face...
Saved in:
| Main Authors: | Yan Li, Bernard A Fox, Cheng Sun, Joe Yeong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e011278.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural killer cell memory: challenges and opportunities for cancer immunotherapy
by: Yuhua Qu, et al.
Published: (2024-12-01) -
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
by: Yong Liu, et al.
Published: (2025-07-01) -
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
by: Man Wang, et al.
Published: (2025-01-01) -
Opportunities, obstacles and challenges of nano-immunotherapy in melanoma
by: Zexing Shan, et al.
Published: (2025-08-01) -
mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01)